Global Clinical Trial Management Systems (CTMS) Industry

NEW YORK, Jan. 21, 2019 /PRNewswire/ -- This report analyzes the worldwide markets for Clinical Trial Management Systems (CTMS) in US$ Million.

Read the full report: https://www.reportlinker.com/p05336779

The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America and Rest of World.

Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 62 companies including many key and niche players such as:
- ArisGlobal, LLC
- BioClinica, Inc.
- Bio-Optronics, Inc.
- DSG, Inc.
- eResearch Technology, Inc.
- IBM Watson Health

Read the full report: https://www.reportlinker.com/p05336779

CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MCP-6
MARKET ANALYSIS, TRENDS, AND FORECASTS, JANUARY 2
CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Clinical Trial Management Systems (CTMS) Gain Ground
Table 1: Increase in R&D Costs of a New Approved Drug: 1980s to 2010s
Benefits Offered by CTMS
Global Market Overview
Clinical Trial Management Systems Market to Post Explosive Growth
Table 2: Increasing Clinical Trial Failure Rate: 1990 and 2010 (includes corresponding Graph/Chart)
Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
Increased Demand for Cloud-based and Other Advanced CTMS
Veeva Vault CTMS Gains Prominence
Key Players in the CTMS Market
Select Major Clinical Trial Management Systems (CTMS) Providers Worldwide
Developed Countries Rule the Market
Pharmaceutical Firms and CROs to Drive Adoption Rate
Noteworthy Transformations in the Global Clinical Trial Sector
Rising Significance of Data Aggregation
Innovative Predictive Modeling Systems
Enhanced Patient Enrollment
Attention on Patient Centricity
Table 3: Percentage of Companies Utilizing Advanced Technologies in Clinical Trials (includes corresponding Graph/Chart)
Table 4: Utilization of Advanced Technologies in Clinical Trials across North America and Europe (includes corresponding Graph/Chart)
Rising Importance of mHealth and Wearable Devices
Improving Clinical Trial Quality

2. SELECT GROWTH DRIVERS AND MARKET TRENDS

Surging Global Population Offers Increased Growth Opportunities
Table 5: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (In Million) (includes corresponding Graph/Chart)
Increased Spend on R&D - An Important Growth Driver
Table 6: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart)
Table 7: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2016E (includes corresponding Graph/Chart)
Clinical Trial Globalization Surges Demand for CTMS
Table 8: Total Number of Registered Clinical Studies: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
Table 9: Total Number of Registered Clinical Trials with Results posted Worldwide: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
Table 10: Total Number of Studies based on Region: 2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
CROs - The Targeted Customers for CTMS
Table 11: Leading CROs Worldwide by Revenue: 2016 (includes corresponding Graph/Chart)
Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand
Noteworthy Contracts of Major CROs
CROs Adept with New Technologies to See More Business in Future
Consolidation of CROs Rampant in the Pharmaceutical Sector
Rise in Clinical Trial Complexities Propels CTMS Demand
Table 12: Increasing Complexity of a Typical Phase 3 Clinical Trial: 2002 Vs. 2012
Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand
Table 13: Global Biopharma % R&D Outsourcing (2014-2020) (includes corresponding Graph/Chart)
Table 14: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals (includes corresponding Graph/Chart)
Adoption of Digital Technologies Gains Pace
Clinical Trial Operators Demand Efficient Data Management Platforms
DLB System€™s Solution with Data Management Tools
Systems Integration Becomes Imperative
Technological Innovations Drive Market Growth
MC10 Introduces BioStampRC System to Capture Clinical Trial Data
UF Health Cancer Center Unveils OnCore® Clinical Trials Management System
UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution

3. CLINICAL TRIAL MANAGEMENT SYSTEMS - AN OVERVIEW

Clinical Trial Management Systems: A Prelude
CTMS Eases Clinical Trials Process
Features/Benefits of a Typical CTMS
CTMS: Core Capabilities
Project Management
Subject and Site Management
Site and Clinical Trial Planning
Clinical Study Management
Financial/Payment Management
Investigator Management
Management of Supply Logistics
Study Documentation/Protocol Management
Reporting and Performance of Clinical Trial
Other Key Capabilities
Types of Clinical Trial Management Systems
Licensed Enterprise Solution
Web-Hosted Solution (CTMS SaaS)
Benefits of a Web-based CTMS
Technology Transfer
Key Features of an Effective CTMS
Major Users of CTMS
Functions of CTMS
For Pharma and Biotech Companies
For Research Sites, Government and Academic Institutions
For Contract Research Organizations
Integrated CTMS Gaining Prominence
Limitations of CTMS
Cost and Customization
Onus on Clinical Team
Implementation Issues
CTMS: Key Challenges
CTMS: Potential Benefits
Important Factors to be Considered while Selecting a CTMS
Regulatory Compliance
CDISC Standards

4. GLOBAL CLINICAL TRIALS - A SNAPSHOT

Overview
Table 15: Clinical Trials Breakdown Initiated in 2016 by Phase: In Percentage (includes corresponding Graph/Chart)
Table 16: Leading Industry Sponsors/Collaborators in 2
(includes corresponding Graph/Chart)
Table 17: Leading Diseases of Phase I-III Clinical Trials Started in 2016 (includes corresponding Graph/Chart)
Role of Contract Research Organizations (CROs) in Clinical Activity
Major CROs with Internally Developed CTMS Systems
CRO Acquisitions: Clinical Trial Technologies

5. PRODUCT INTRODUCTIONS/INNOVATIONS

TCS Unveils Connected Clinical Trials
Trial by Fire Solutions Releases SimpleTrials 2.0
PAREXEL Unveils Patient Sensor Solution
ASCO & Friends of Cancer Research Launches Initiative to Modernize Eligibility Criteria for Clinical Trials
Medidata Launches New Payment Technology
ClinDatrix Unveils Oracle Health Sciences InForm 6.1 and Oracle Argus 8.0
Bioclinica Introduces OnPoint Direct CTMS
TransCelerate BioPharma Introduces SIP Technology
PAREXEL Introduces IMPACT Express CTMS
Veeva Systems Introduces Clinical Trials Study Startup Solution
Ottawa Hospital Introduces Clinical Trial of Double-Virus Cancer
Comprehend Systems Unveils Quality Solution for ClinOps
KCR S.A., Introduces Innovative Clinical Trial Data Platform

6. RECENT INDUSTRY ACTIVITY

OmniComm Systems Signs LOI to Acquire Algorics
Bio-Optronics Partners with Complion
Singota Solutions Enters into Partnership with Slope.io
Anju Software Acquires ClinPlus
Bio-Optronics and Adventist Health System Rolls out the Clinical Conductor CTMS
Medidata Partners with Karyopharm
ERT Secures 2016 Scrip Award
Medidata Solutions Provides Cloud Platform & Mobile Health Capabilities to Techfields Pharma
ICON Takes Over Clinical Research Management
Biomedical Systems Partners with Foundry Health
Medidata Cloud Technology Choosen to Support Biogen Clinical Trials
UPS Expands Healthcare-Specific Capabilities to Support Clinical Trials
PFS Clinical Partners with Velos
Green Circle Health Partners with Integrated Clinical Solutions
Pfizer Selects Oracle Cloud for Clinical Data Management and Trial Management
LSK Global PS Expands Use of Medidata Clinical Cloud Platform
Bioclinica Integrates with Parallel 6€™s Clinical Reach
FMD Adopts Oracle€™s Cloud-Based Clinical Data Management Solutions
Nextrials Presents New Opportunities for Healthcare Providers & Researchers
Medidata Expands Adoption of the Medidata Clinical Cloud
MedStar Health Collaborates with Forte Research Systems
PFS Clinical Partners with Clinical Conductor CTMS
Bioclinica Acquires Clinverse
ICON Takes Over PMG Research
BioClinica Integrates OnPoint CTMS with Clireo eTMF
eResearchTechnology, Inc.€™s Insights Cloud Replaces Traditional CTMS Functionality
IBM Acquires Merge Healthcare
Guardian Research Network Collaborates with Molecular Health
Quintiles Enters into Definitive Agreement with Quest Diagnostics
Accenture Selects Medidata€™s Technology for Expansion of Cloud Capabilities for R&D
Medidata Partners with Peking University
PPDI Migrates CTMS to Oracle Health Sciences Cloud
CROS NT Partners with DATATRAK
Medidata partners with Garmin

7. FOCUS ON SELECT PLAYERS

ArisGlobal, LLC (USA)
BioClinica, Inc. (USA)
Bio-Optronics, Inc. (USA)
DSG, Inc. (USA)
eResearch Technology, Inc. (USA)
IBM Watson Health (USA)
MedNet Solutions (USA)
Medidata Solutions (USA)
Nextrials, Inc. (USA)
Oracle Corp. (USA)
PAREXEL International Corp. (USA)
Trial By Fire Solutions, LLC (USA)
Veeva Systems, Inc. (USA)
Winchester Business Systems (USA)

8. GLOBAL MARKET PERSPECTIVE

Table 18: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 20: World 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011, 2
and 2024 (includes corresponding Graph/Chart)
Table 21: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery Mode - Percentage Breakdown of Revenues for Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS Markets for Years 2011, 2017 and 2
(includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A.Market Analysis
United States: The Largest Market for CTMS Worldwide
Table 24: The US Life Science R&D Spending: 2014 - 2
(includes corresponding Graph/Chart)
Growing Demand from CROs Drives the CTMS Market
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
Product Launches
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 25: The US Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2
through 2024 (includes corresponding Graph/Chart)
Table 26: The US Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart)

2. CANADA

Market Analysis
Table 27: Canadian Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2
through 2024 (includes corresponding Graph/Chart)
Table 28: Canadian Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart)

3. EUROPE

A.Market Analysis
Clinical Trial Regulation to Strengthen EU€™s Presence in Clinical Research
EMA Focuses on Enhancing Patient Safety in First-In-Human Clinical Trials
Brexit Referendum to Threaten UK€™s Position as Leading Hub for Clinical Trials
Product Launch
B.Market Analytics
Table 29: European Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2
through 2024 (includes corresponding Graph/Chart)
Table 30: European Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart)

4. ASIA-PACIFIC

A.Market Analysis
R&D Outsourcing in Life Sciences on the Rise
Asia: The Most Preferred Destination for Clinical Trials
Table 31: Total Number of Clinical Studies Conducted in Asia: 2017 (includes corresponding Graph/Chart)
B.Market Analytics
Table 32: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 33: Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 34: Asia-Pacific 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

4a. CHINA
A.Market Analysis
China Rapidly Emerges as Compelling Destination for Clinical Trials
B.Market Analytics
Table 35: Chinese Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2
through 2024 (includes corresponding Graph/Chart)
Table 36: Chinese Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart)

4b. REST OF ASIA PACIFIC
A.Market Analysis
Review of Select Markets
India
A Thriving Clinical Trials Market
Reasons for Outsourcing to India
Approval Process in India
Regulatory Issues
Improper Functioning of CROs
Clinical Study Liabilities
Access to Treatment Following Clinical Trial
Legislation to Monitor Drug Trials
FDA and WHO Issue Notices to Drug Makers Using Data from Indian CRO
Australia
Australia to Retain Position as Compelling Hub for Early- Phase Clinical Research
Initiatives Taken by Australian Government for Popularizing Clinical Trials
Product Approval
Strategic Corporate Developments
B.Market Analytics
Table 37: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 38: Rest of Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart)

5. LATIN AMERICA

A.Market Analysis
Latin America: An Emerging Market for Clinical Trials
B.Market Analytics
Table 39: Latin American Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 40: Latin American Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 41: Latin American 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2011, 2017 and 2
(includes corresponding Graph/Chart)

5a. BRAZIL
Market Analysis
Table 42: Brazilian Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2
through 2024 (includes corresponding Graph/Chart)
Table 43: Brazilian Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart)

5b. REST OF LATIN AMERICA
Market Analysis
Table 44: Rest of Latin American Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 45: Rest of Latin American Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2
through 2015 (includes corresponding Graph/Chart)

6. REST OF WORLD

Market Analysis
Table 46: Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 47: Rest of World Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled:
The United States (45) Canada (1) Japan (1) Europe (9) - Germany (3) - The United Kingdom (2) - Italy (1) - Rest of Europe (3) Asia-Pacific (Excluding Japan) (6)
Read the full report: https://www.reportlinker.com/p05336779

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/global-clinical-trial-management-systems-ctms-industry-300781459.html

SOURCE Reportlinker